Canada markets close in 2 hours 23 minutes

Tetra Bio-Pharma Inc. (TBP.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.05500.0000 (0.00%)
As of 01:22PM EDT. Market open.
Full screen
Previous Close0.0550
Open0.0600
Bid0.0550 x N/A
Ask0.0600 x N/A
Day's Range0.0550 - 0.0600
52 Week Range0.0500 - 0.3400
Volume64,150
Avg. Volume286,198
Market Cap23.263M
Beta (5Y Monthly)1.99
PE Ratio (TTM)N/A
EPS (TTM)-0.1100
Earnings DateApr 13, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Baystreet

    Stocks in play: Tetra Bio-Pharma Inc

    Announces the launch of its new wholly owned subsidiary 'Tetra Bio-Pharma Australia Pty Ltd', an Australian-based ...

  • CNW Group

    Tetra Bio-Pharma Opens New Subsidiary in Australia and Provides Regulatory Update

    Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development announces the launch of its new wholly owned subsidiary 'Tetra Bio-Pharma Australia Pty Ltd' ("TBP-AU"), an Australian-based research company focused on the execution of clinical trials in Australia. This represents Tetra's second foreign subsidiary and is in line with the Company's global expansion strategy for QIXLEEF™, and other future drug can

  • CNW Group

    Tetra Bio-Pharma Announces Voting Results of 2022 Annual General and Special Meeting

    Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development, held its annual general and special meeting (the "Meeting") of its holders of common shares (the "Shareholders") virtually on May 30, 2022. The Company is pleased to announce that all matters presented for approval at the Meeting were approved, except with respect to the proposed share consolidation of the issued and outstanding common shares of